BCAP31 Antikörper (AA 1-242)
Kurzübersicht für BCAP31 Antikörper (AA 1-242) (ABIN7599142)
Target
Alle BCAP31 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-242
-
Verwendungszweck
- Anti-BAP31/BCAP31 Antibody Picoband®
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Produktmerkmale
- Anti-BAP31/BCAP31 Antibody Picoband® (ABIN7599142). Tested in WB, IHC, ICC/IF, IP, Flow Cytometry, ELISA applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human BAP31/BCAP31 recombinant protein (Position: M1-D242). Human BAP31/BCAP31 shares 91.2% amino acid (aa) sequence identity with mouse BAP31/BCAP31.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western blot, 0.25-0.5 μg/mL, Human, Mouse, Rat
Immunohistochemistry, 2-5 μg/mL, Human
Immunocytochemistry/Immunofluorescence, 5 μg/mL, Human
Immunoprecipitation, 2-4 μg/mL, Human
Flow Cytometry (Fixed), 1-3 μg/1x106 cells, Human
ELISA, 0.1-0.5 μg/mL, Human
1. Adachi, T., Schamel, W. W. A., Kim, K.-M., Watanabe, T., Becker, B., Nielsen, P. J., Reth, M. The specificity of association of the IgD molecule with the accessory proteins BAP31/BAP29 lies in the IgD transmembrane sequence. EMBO J. 15: 1534-1541, 1996. 2. Cacciagli, P., Sutera-Sardo, J., Borges-Correia, A., Roux, J.-C., Dorboz, I., Desvignes, J.-P., Badens, C., Delepine, M., Lathrop, M., Cau, P., Levy, N., Girard, N., Sarda, P., Boespflug-Tanguy, O., Villard, L. Mutations in BCAP31 cause a severe X-linked phenotype with deafness, dystonia, and central hypomyelination and disorganize the Golgi apparatus. Am. J. Hum. Genet. 93: 579-586, 2013. 3. Lambert, G., Becker, B., Schreiber, R., Boucherot, A., Reth, M., Kunzelmann, K. Control of cystic fibrosis transmembrane conductance regulator expression by BAP31. J. Biol. Chem. 276: 20340-20345, 2001. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Konzentration
- 500 μg/mL
-
Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.
-
-
- BCAP31 (B-Cell Receptor-Associated Protein 31 (BCAP31))
-
Andere Bezeichnung
- BCAP31
-
Hintergrund
-
Synonyms: BCAP31, BAP31, DXS1357E, B-cell receptor-associated protein 31, BCR-associated protein 31, Bap31, 6C6-AG tumor-associated antigen, Protein CDM, p28
Background: B-cell receptor-associated protein 31 is a protein that in humans is encoded by the BCAP31 gene.
-
Molekulargewicht
- 28 kDa
-
Gen-ID
- 10134
-
UniProt
- P51572
-
Pathways
- Positive Regulation of Endopeptidase Activity
Target
-